Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2025 07:00 ET | Source: Petal Health

Petal Health and Shoppers Drug Mart Collaborate to Expand Access to Care Across Canada

Montréal, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Petal Health, a leader in health technology and improving access to care for patients and providers, and Shoppers Drug Mart are working together to...
September 29, 2025 08:05 ET | Source: Boehringer Ingelheim Limited

Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments

Ridgefield, Connecticut, U.S. Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for...
November 19, 2024 08:15 ET | Source: Boehringer Ingelheim Limited

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the...
November 19, 2024 08:00 ET | Source: Novartis Pharma AG

Novartis ranks first in 2024 Access to Medicine Index

The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topics Novartis malaria access plans, widespread registration...
September 27, 2024 06:05 ET | Source: Boehringer Ingelheim

Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities

Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable...
August 28, 2023 01:15 ET | Source: Novartis Pharma AG

Sandoz completes acquisition of leading antifungal agent Mycamine® from Astellas, reinforcing leading global anti-infectives portfolio

Sandoz completes acquisition of worldwide brand rights for Mycamine® (micafungin sodium) from Astellas Leading global echinocandin, one of three major antifungal classes, will significantly...
August 25, 2023 01:15 ET | Source: Novartis Pharma AG

Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only FDA-approved biosimilar for relapsing forms of multiple sclerosis

Biosimilar Tyruko® approved for all indications of reference medicine, with same dosing and administration schedule Sandoz continues to expand access to much-needed medications for patients...
August 18, 2023 01:25 ET | Source: Novartis Pharma AG

Novartis publie l’invitation à l’AGE et la brochure d’information aux actionnaires. Sandoz publie le prospectus de cotation avant le vote sur la proposition de scission

Annonce ad hoc en vertu de l’art. 53 LR Invitation à l’assemblée générale extraordinaire de Novartis du 15 septembre 2023 et publication d’une brochure d’information destinée aux...
August 18, 2023 01:25 ET | Source: Novartis Pharma AG

Novartis publiziert Einladung und Aktionärsbroschüre zur ausserordentlichen Generalversammlung. Sandoz veröffentlicht den Kotierungsprospekt im Vorfeld der Abstimmung zum vorgeschlagenen Spin-off

Ad-hoc-Meldung nach Art. 53 LR Einladung zur ausserordentlichen Generalversammlung von Novartis am 15. September 2023 und Informationsbroschüre für Aktionärinnen und Aktionäre publiziertSandoz...
August 18, 2023 01:25 ET | Source: Novartis Pharma AG

Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz publishes Listing Prospectus ahead of proposed Spin-off vote

Ad hoc announcement pursuant to Art. 53 LR Invitation to Novartis Extraordinary General Meeting on September 15, 2023, and Shareholder Information Brochure issuedSandoz Listing Prospectus...